ITGAM and neoplasm: Taken together, these results suggest that CD11b modulation elicits its efficacy in controlling lung tumor growth partly by reducing TAM frequency in tumors and partly by increasing the ratio of M1/M2 macrophages, that results in induction of T cell-mediated anti-tumor immunity.